These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 9845037)

  • 1. Neurobehavioural basis for the pharmacotherapy of alcoholism: current and future directions.
    Anton RF
    Alcohol Alcohol Suppl; 1996 Mar; 31(1):43-53. PubMed ID: 9845037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurobehavioural basis for the pharmacotherapy of alcoholism: current and future directions.
    Anton RF
    Alcohol Alcohol; 1996 Mar; 31 Suppl 1():43-53. PubMed ID: 8737000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of serotonin (5-HT) and opiate-based drugs in the pharmacotherapy of alcohol dependence: an overview of the preclinical data.
    Lê AD; Tomkins DM; Sellers EM
    Alcohol Alcohol; 1996 Mar; 31 Suppl 1():27-32. PubMed ID: 8736998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noradrenergic vs serotonergic antidepressant with or without naltrexone for veterans with PTSD and comorbid alcohol dependence.
    Petrakis IL; Ralevski E; Desai N; Trevisan L; Gueorguieva R; Rounsaville B; Krystal JH
    Neuropsychopharmacology; 2012 Mar; 37(4):996-1004. PubMed ID: 22089316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of serotonin (5-HT) and opiate-based drugs in the pharmacotherapy of alcohol dependence: an overview of the preclinical data.
    Lê AD; Tomkins DM; Sellers EM
    Alcohol Alcohol Suppl; 1996 Mar; 31(1):27-32. PubMed ID: 9845035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occurrence and management of depression in the context of naltrexone treatment of alcoholism.
    Farren CK; O'Malley SS
    Am J Psychiatry; 1999 Aug; 156(8):1258-62. PubMed ID: 10450269
    [No Abstract]   [Full Text] [Related]  

  • 7. Current pharmacotherapies of alcoholism: a U.S. perspective.
    Anton RF; Swift RM
    Am J Addict; 2003; 12(s1):s53-s68. PubMed ID: 14972780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of naltrexone and acamprosate for alcoholism treatment: a meta-analysis.
    Kranzler HR; Van Kirk J
    Alcohol Clin Exp Res; 2001 Sep; 25(9):1335-41. PubMed ID: 11584154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of serotonin (5-hydroxytryptamine) reuptake inhibitors in the treatment of alcoholism.
    Lejoyeux M
    Alcohol Alcohol Suppl; 1996 Mar; 31(1):69-75. PubMed ID: 9845041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of selective serotonin reuptake inhibitors in treating alcoholic subtypes.
    Pettinati HM
    J Clin Psychiatry; 2001; 62 Suppl 20():26-31. PubMed ID: 11584872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of serotonin (5-hydroxytryptamine) reuptake inhibitors in the treatment of alcoholism.
    Lejoyeux M
    Alcohol Alcohol; 1996 Mar; 31 Suppl 1():69-75. PubMed ID: 8737004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin's Complex Role in Alcoholism: Implications for Treatment and Future Research.
    Marcinkiewcz CA; Lowery-Gionta EG; Kash TL
    Alcohol Clin Exp Res; 2016 Jun; 40(6):1192-201. PubMed ID: 27161942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioid antagonists for alcohol dependence.
    Srisurapanont M; Jarusuraisin N
    Cochrane Database Syst Rev; 2000; (3):CD001867. PubMed ID: 10908513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in the pharmacotherapy of alcoholism.
    Myrick H; Anton R
    Curr Psychiatry Rep; 2004 Oct; 6(5):332-8. PubMed ID: 15355755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naltrexone and disulfiram in patients with alcohol dependence and comorbid post-traumatic stress disorder.
    Petrakis IL; Poling J; Levinson C; Nich C; Carroll K; Ralevski E; Rounsaville B
    Biol Psychiatry; 2006 Oct; 60(7):777-83. PubMed ID: 17008146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacological effects of a mu-opioid receptor antagonist naltrexone on alcohol dependence].
    Kato H
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2008 Oct; 43(5):697-704. PubMed ID: 19068776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New drug treatments for alcohol problems: a critical appraisal.
    Moncrieff J; Drummond DC
    Addiction; 1997 Aug; 92(8):939-47; discussion 949-64. PubMed ID: 9376777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in the adoption of medications for alcohol dependence.
    Ducharme LJ; Knudsen HK; Roman PM
    J Clin Psychopharmacol; 2006 Dec; 26 Suppl 1():S13-9. PubMed ID: 17114950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naltrexone for the treatment of alcoholism: clinical findings, mechanisms of action, and pharmacogenetics.
    Ray LA; Chin PF; Miotto K
    CNS Neurol Disord Drug Targets; 2010 Mar; 9(1):13-22. PubMed ID: 20201811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the serotonergic system in the neurobiology of alcoholism: implications for treatment.
    Johnson BA
    CNS Drugs; 2004; 18(15):1105-18. PubMed ID: 15581381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.